Stockreport

ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright Chat [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF top-line data due in Q2 and a potential supplemental BLA filing ~4–5 months after the readout that could lead to approval around mid-2027 if positive. Early combinatio [Read more]